Malaria and artemisinin derivatives: an updated review.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Mini-Reviews in Medical Chemistry

• Publication date

  2013-10-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/13895575113136660097PMID 24070206
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular interaction of artemisinin with translationally controlled tumor protein (TCTP) of Plasmodium falciparum.

  2013cited by this paper
• Ternary system of dihydroartemisinin with hydroxypropyl-β-cyclodextrin and lecithin: simultaneous enhancement of drug solubility and stability in aqueous solutions.

  2013cited by this paper
• Dihydroartemisinin induces autophagy and inhibits the growth of iron-loaded human myeloid leukemia K562 cells via ROS toxicity

  2012cited by this paper
• Improved physicochemical characteristics of artemisinin-nicotinamide solid dispersions by solvent evaporation and freeze dried methods.

  2012cited by this paper
• In Vitro Cardiovascular Effects of Dihydroartemisin-Piperaquine Combination Compared with Other Antimalarials

  2012cited by this paper
• Formulation design and in vivo antimalarial evaluation of lipid-based drug delivery systems for oral delivery of β-arteether.

  2012cited by this paper
• Antiproliferative effects of artemisinin on human breast cancer cells requires the downregulated expression of the E2F1 transcription factor and loss of E2F1-target cell cycle genes

  2012cited by this paper
• Molecular monitoring of Plasmodium falciparum resistance to antimalarial drugs after adoption of sulfadoxine-pyrimethamine plus artesunate as the first line treatment in Iran.

  2012cited by this paper
• Growth inhibitory effect of dihydroartemisinin on Bcr/Abl+ chronic myeloid leukemia K562 cells involve AKT, ERK and NF-κB modulation

  2012cited by this paper
• No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali.

  2012cited by this paper
• Ex vivo drug sensitivity profiles of Plasmodium falciparum field isolates from Cambodia and Thailand, 2005 to 2010, determined by a histidine-rich protein-2 assay

  2012cited by this paper
• Implications of Plasma Protein Binding for Pharmacokinetics and Pharmacodynamics of the γ-Secretase Inhibitor RO4929097

  2012cited by this paper
• Dihydroartemisinin inhibits the human erythroid cell differentiation by altering the cell cycle.

  2012cited by this paper
• Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study

  2012cited by this paper
• Dihydroartemisinin-induced inhibition of proliferation in BEL-7402 cells: an analysis of the mitochondrial proteome.

  2012cited by this paper
• Clinical tolerability of artesunate-amodiaquine versus comparator treatments for uncomplicated falciparum malaria: an individual-patient analysis of eight randomized controlled trials in sub-Saharan Africa

  2012cited by this paper
• Artesunate Dose Escalation for the Treatment of Uncomplicated Malaria in a Region of Reported Artemisinin Resistance: A Randomized Clinical Trial

  2011cited by this paper
• Dissolution enhancement of artemisinin with β-cyclodextrin.

  2011cited by this paper
• Artesunate enhances radiosensitivity of human non-small cell lung cancer A549 cells via increasing NO production to induce cell cycle arrest at G2/M phase.

  2011cited by this paper
• Can pharmacogenomics improve malaria drug policy?

  2011cited by this paper
• Synthesis of Artemiside and Its Effects in Combination with Conventional Drugs against Severe Murine Malaria

  2011cited by this paper
• Hypoxia modulates the effect of dihydroartemisinin on endothelial cells.

  2011cited by this paper
• Drug-Resistant Malaria: The Era of ACT

  2010cited by this paper
• Artemisone effective against murine cerebral malaria

  2010cited by this paper
• Artemisone Uptake in Plasmodium falciparum-Infected Erythrocytes

  2010cited by this paper
• Exploring the Contribution of Candidate Genes to Artemisinin Resistance in Plasmodium falciparum

  2010cited by this paper
• High heritability of malaria parasite clearance rate indicates a genetic basis for artemisinin resistance in western Cambodia.

  2010cited by this paper
• Physicochemical characterization of artemether solid dispersions with hydrophilic carriers by freeze dried and melt methods

  2010cited by this paper
• Selective toxicity of dihydroartemisinin on human CD34+ erythroid cell differentiation.

  2010cited by this paper
• Artesunate plus sulfadoxine/pyrimethamine versus praziquantel in the treatment of Schistosoma mansoni in eastern Sudan.

  2009cited by this paper
• Modulation of the Antifungal Activity of New Medicinal Plant Extracts Active on Candida glabrata by the Major Transporters and Regulators of the Pleiotropic Drug-Resistance Network in Saccharomyces cerevisiae

  2009cited by this paper
• Artemisinin derivatives inhibit Toxoplasma gondii in vitro at multiple steps in the lytic cycle.

  2009cited by this paper
• Artemisone and Artemiside Control Acute and Reactivated Toxoplasmosis in a Murine Model

  2009cited by this paper
• Dihydroartemisinin-cyclodextrin complexation: Solubility and stability

  2009cited by this paper
• Evaluation of Artemisone Combinations in Aotus Monkeys Infected with Plasmodium falciparum

  2009cited by this paper
• The evolution of drug-resistant malaria.

  2009cited by this paper
• Embryotoxicity of the artemisinin antimalarials and potential consequences for use in women in the first trimester.

  2009cited by this paper
• The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia

  2009cited by this paper
• Artemether/hydroxypropyl-beta-cyclodextrin host-guest system: characterization, phase-solubility and inclusion mode.

  2009cited by this paper
• Artemisinin resistance in Plasmodium falciparum malaria.

  2009cited by this paper
• Evidence of artemisinin-resistant malaria in western Cambodia.

  2008cited by this paper
• Solid dispersions of dihydroartemisinin in polyvinylpyrrolidone

  2008cited by this paper
• The antiviral activities of artemisinin and artesunate.

  2008cited by this paper
• Declining Artesunate-Mefloquine Efficacy against Falciparum Malaria on the Cambodia–Thailand Border

  2008cited by this paper
• The Antimalarial Artemisone is an Efficient Heme Alkylating Agent

  2008cited by this paper
• Developmental toxicity of artesunate in the rat: comparison to other artemisinins, comparison of embryotoxicity and kinetics by oral and intravenous routes, and relationship to maternal reticulocyte count.

  2008cited by this paper
• Sensitive periods for developmental toxicity of orally administered artesunate in the rat.

  2008cited by this paper
• Artesunate: developmental toxicity and toxicokinetics in monkeys.

  2008cited by this paper
• The antischistosomal efficacies of artesunate–sulfamethoxypyrazine–pyrimethamine and artemether–lumefantrine administered as treatment for uncomplicated, Plasmodium falciparum malaria

  2008cited by this paper
• Heme activates artemisinin more efficiently than hemin, inorganic iron, or hemoglobin.

  2008cited by this paper
• Investigations of the effects of the antimalarial drug dihydroartemisinin (DHA) using the Frog Embryo Teratogenesis Assay-Xenopus (FETAX).

  2008cited by this paper
• Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border.

  2007cited by this paper
• Amodiaquine combined with sulfadoxine/pyrimethamine versus artemisinin-based combinations for the treatment of uncomplicated falciparum malaria in Africa: a meta-analysis.

  2007cited by this paper
• Differential effects on angiogenesis of two antimalarial compounds, dihydroartemisinin and artemisone: implications for embryotoxicity.

  2007cited by this paper
• Stability of artesunate in pharmaceutical solvents.

  2007cited by this paper
• Artemisinins Inhibit Trypanosoma cruzi and Trypanosoma brucei rhodesiense In Vitro Growth

  2007cited by this paper
• Cognitive Impairment After Cerebral Malaria in Children: A Prospective Study

  2007cited by this paper
• Effect of artemether administered alone or in combination with praziquantel to mice infected with Plasmodium berghei or Schistosoma mansoni or both.

  2006cited by this paper
• In vivo and in vitro investigations of the effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos.

  2006cited by this paper
• Artemisone--a highly active antimalarial drug of the artemisinin class.

  2006cited by this paper
• Inhibition of Angiogenesis and of Erythroid Differentiation by Artemisinin Derivatives

  2006cited by this paper
• Artesunate Suppositories versus Intramuscular Artemether for Treatment of Severe Malaria in Children in Papua New Guinea

  2006cited by this paper
• Malaria Parasites Can Develop Stable Resistance to Artemisinin but Lack Mutations in Candidate Genes atp6 (Encoding the Sarcoplasmic and Endoplasmic Reticulum Ca2+ ATPase), tctp, mdr1, and cg10

  2006cited by this paper
• The history of qing hao in the Chinese materia medica.

  2006cited by this paper
• Artesunate-induced depletion of embryonic erythroblasts precedes embryolethality and teratogenicity in vivo.

  2006cited by this paper
• Production of the antimalarial drug precursor artemisinic acid in engineered yeast

  2006cited by this paper
• The evaluation of radiolabeled artesunate on tissue distribution in rats and protein binding in humans.

  2006cited by this paper
• Effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos in vitro.

  2006cited by this paper
• Dihydroartemisinin enhances radiosensitivity of human glioma cells in vitro

  2006cited by this paper
• The global distribution of clinical episodes of Plasmodium falciparum malaria

  2005cited by this paper
• Effectiveness of antimalarial drugs.

  2005cited by this paper
• Clinical Pharmacokinetics of the Diastereomers of Arteether in Healthy Volunteers

  2005cited by this paper
• Efficacy and safety of artemether-lumefantrine (Coartem) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria.

  2005cited by this paper
• WHO, the Global Fund, and medical malpractice in malaria treatment.

  2004cited by this paper
• Artesunate combinations for treatment of malaria: meta-analysis.

  2004cited by this paper
• Identification of an antimalarial synthetic trioxolane drug development candidate

  2004cited by this paper
• Antimalarial Drug Toxicity

  2004cited by this paper
• Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron.

  2004cited by this paper
• Experimental designed optimisation and stability evaluation of dry suspensions with artemisinin derivatives for paediatric use.

  2004cited by this paper
• Comparative Pharmacokinetics of Intramuscular Artesunate and Artemether in Patients with Severe Falciparum Malaria

  2004cited by this paper
• Artemisinin derivatives: toxic for laboratory animals, safe for humans?

  2004cited by this paper
• Disposition of Artesunate and Dihydroartemisinin after Administration of Artesunate Suppositories in Children from Papua New Guinea with Uncomplicated Malaria

  2004cited by this paper
• Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit.

  2004cited by this paper
• A circular dichroism and structural study of the inclusion complex artemisinin-β-cyclodextrin

  2004cited by this paper
• Quantitative structure-activity relationship of sesquiterpene lactones as inhibitors of the transcription factor NF-kappaB.

  2004cited by this paper
• Artemisinins target the SERCA of Plasmodium falciparum

  2003cited by this paper
• Artesunate plus sulfadoxine-pyrimethamine for uncomplicated malaria in Kenyan children: a randomized, double-blind, placebo-controlled trial.

  2003cited by this paper
• Population pharmacokinetics of artemether and dihydroartemisinin following single intramuscular dosing of artemether in African children with severe falciparum malaria.

  2003cited by this paper
• Therapeutic equivalence of a low dose artemisinin formulation in falciparum malaria patients

  2003cited by this paper
• Artemether Bioavailability after Oral or Intramuscular Administration in Uncomplicated Falciparum Malaria

  2003cited by this paper
• Interaction of artemisinin and its related compounds with hydroxypropyl-beta-cyclodextrin in solution state: experimental and molecular-modeling studies.

  2003cited by this paper
• Structure-activity relationships of the antimalarial agent artemisinin. 8. design, synthesis, and CoMFA studies toward the development of artemisinin-based drugs against leishmaniasis and malaria.

  2003cited by this paper
• Improvement of the dissolution rate of artemisinin by means of supercritical fluid technology and solid dispersions.

  2003cited by this paper
• Assessment of the neurotoxicity of oral dihydroartemisinin in mice.

  2002cited by this paper
• Neurotoxic Mode of Action of Artemisinin

  2002cited by this paper
• Epidemiology of drug-resistant malaria.

  2002cited by this paper
• Comparison of Oral Artesunate and Dihydroartemisinin Antimalarial Bioavailabilities in Acute Falciparum Malaria

  2002cited by this paper
• Efficacy of artesunate and praziquantel in Schistosoma haematobium infected schoolchildren.

  2002cited by this paper
• Dose-finding and efficacy study for i.m. artemotil (beta-arteether) and comparison with i.m. artemether in acute uncomplicated P. falciparum malaria.

  2002cited by this paper
• Delayed clearance of Plasmodium falciparum in patients with human immunodeficiency virus co-infection treated with artemisinin.

  2002cited by this paper

• Development and evaluation of novel zein-based artemisinin sustained-release formulation for treating drug-resistant malaria

  2026cites this paper
• Supercritical CO2 extraction of artemisinin from Artemisia annua plant and the biotechnological production of artemisinin precursors: A dual-focus review

  2025cites this paper
• In-silico identification of sulfur and selenium analogous to artemisinin as potential antimalarial drug candidates

  2025cites this paper
• Artesunate: a potential drug for the prevention and treatment from hepatitis to hepatocellular carcinoma.

  2024cites this paper
• Integrative metabolomic and transcriptomic reveals potential mechanism for promotion of ginsenoside synthesis in Panax ginseng leaves under different light intensities

  2023cites this paper
• Dihydroartemisinin Promotes Neural Stem Cell Differentiation into Oligodendrocytes via STAT6/Chi3l3 Signaling Pathway in Microglia

  2023cites this paper
• Novel Bis-Artemisinin-Phloroglucinol hybrid molecules with dual anticancer and immunomodulatory Activities: Synthesis and evaluation.

  2023cites this paper
• Dihydroartemisinin inhibits plasmid transfer in drug-resistant Escherichia coli via limiting energy supply

  2023cites this paper
• Genotype Variation of Polyphenol Content and Antioxidant Activity of Artemisia balchanorum Krasch. × Artemisia taurica Willd

  2023cites this paper
• Urea and thiourea derivatives in the synthesis of hexaoxazadispiroalkane carboxamides

  2023cites this paper
• Lupeol Acetate and α-Amyrin Terpenes Activity against Trypanosoma cruzi: Insights into Toxicity and Potential Mechanisms of Action

  2023cites this paper
• A terpenoid-rich extract from Clethra fimbriata exhibits anti-Trypanosoma cruzi activity and induces T cell cytokine production

  2022cites this paper
• Modulation of mice immune responses against Schistosoma mansoni infection with anti-schistosomiasis drugs: Role of interleukin-4 and interferon-gamma

  2022cites this paper
• Ferrous iron–activatable drug conjugate achieves potent MAPK blockade in KRAS-driven tumors

  2022cites this paper
• Construction and optimization of Saccharomyces cerevisiae for synthesizing forskolin

  2022cites this paper
• Preparation, characterization, and evaluation of eosin B–loaded nano-liposomes for growth inhibition of Plasmodium falciparum

  2022cites this paper
• Urea and Thiourea Derivatives in the Synthesis of Hexaoxaazadispiroalkanecarboxamides

  2022cites this paper
• Commercialized artemisinin derivatives combined with colistin protect against critical Gram-negative bacterial infection

  2022cites this paper
• Plant-derived compounds for the treatment of schistosomiasis: Improving efficacy via nano-drug delivery

  2022cites this paper
• Dimeric Artesunate Glycerophosphocholine Conjugate Nano-Assemblies as Slow-Release Antimalarials to Overcome Kelch 13 Mutant Artemisinin Resistance

  2022cites this paper
• Dihydroartemisinin, an active metabolite of artemisinin, interferes with Leishmania braziliensis mitochondrial bioenergetics and survival

  2021cites this paper
• Effects of Light on Secondary Metabolite Biosynthesis in Medicinal Plants

  2021cites this paper
• Studies on Activities and Chemical Characterization of Medicinal Plants in Search for New Antimalarials: A Ten Year Review on Ethnopharmacology

  2021influential citation
• Progress in heterologous biosynthesis of forskolin

  2021cites this paper
• Hydrazines in the Synthesis of Cytotoxic N-Aryl(alkyl)-N-(hexaoxazadispiroalkyl)amines

  2020cites this paper
• In vitro Activity of Ozoroa pulcherrima Schweinf. Extracts and Fractions on Schistosoma mansoni Cercariae and Adult Worms

  2020cites this paper
• Exploiting KRAS-driven Ferroaddiction in Cancer Through Ferrous Iron-Activatable Drug Conjugates (FeADC)

  2020cites this paper
• Fluorinated scaffolds for antimalarial drug discovery

  2020cites this paper
• Recent Progress in the Development of New Antimalarial Drugs with Novel Targets

  2020cites this paper
• Recent Progress in the Development of New Antimalarial Drugs with Novel Targets

  2020cites this paper
• Bicyclic 6-6 Systems: Four Heteroatoms 1:3

  2020cites this paper
• Recent Progress in the Development of New Antimalarial Drugs with Novel Targets

  2020cites this paper
• Overcoming cancer therapeutic bottleneck by drug repurposing

  2020cites this paper
• Global research on artemisinin and its derivatives: Perspectives from patents

  2020cites this paper
• Development of artemisinin resistance in malaria therapy.

  2019cites this paper
• In vitro and in vivo evaluation of six artemisinin derivatives against Schistosoma mansoni

  2019cites this paper
• Long-term add-on therapy (compassionate use) with oral artesunate in patients with metastatic breast cancer after participating in a phase I study (ARTIC M33/2).

  2019cites this paper
• Sustained and controlled release of herbal medicines: The concept of synchronized release

  2019cites this paper
• Analysis of Artemisia annua extracts and related products by high performance liquid chromatography-tandem mass spectrometry coupled to sample treatment miniaturisation.

  2019cites this paper
• Plant Metabolites as New Leads to Drug Discovery

  2019cites this paper
• Leishmanicidal activity of Artemisinin against cutaneous Leishmaniasis, in Vitro

  2019cites this paper
• Catalytic Enantioselective Synthesis of a Pyrrolizidine-Alkaloid-Inspired Compound Collection with Antiplasmodial Activity.

  2018cites this paper
• Intravenous Human Serum Albumin (HSA)-Bound Artemether Nanoparticles for Treatment of Severe Malaria

  2018cites this paper
• Terpenoids as Emerging Therapeutic Agents: Cellular Targets and Mechanisms of Action against Protozoan Parasites

  2018cites this paper
• Artemether and Praziquantel: Origin, Mode of Action, Impact, and Suggested Application for Effective Control of Human Schistosomiasis

  2018cites this paper
• Evaluation of Efficacy and Safety of Artemisinin Derivatives for Treatment of Severe Malaria: A Meta-Analysis Approach

  2018cites this paper
• Synthesis of the Polyoxygenated Cyclohexanoid Core of Bioactive Glycosides Xylosmin and Flacourtosides E and F.

  2018cites this paper
• Sesquiterpene Synthase‐Catalysed Formation of a New Medium‐Sized Cyclic Terpenoid Ether from Farnesyl Diphosphate Analogues

  2018cites this paper
• Optimization and evaluation of lipid emulsions for intravenous co-delivery of artemether and lumefantrine in severe malaria treatment

  2018cites this paper
• Biotechnological approaches for artemisinin production in Artemisia

  2018cites this paper
• Bioavailability and Pharmacokinetics of Dihydroartemisinin (DHA) and its Analogs—Mechanistic Studies on its ADME

  2018cites this paper
• The structural modification of natural products for novel drug discovery

  2017cites this paper
• Anti-angiogenic properties of artemisinin derivatives (Review).

  2017cites this paper
• Overexpression of a type‐I isopentenyl pyrophosphate isomerase of Artemisia annua in the cytosol leads to high arteannuin B production and artemisinin increase

  2017cites this paper
• Exploring the global animal biodiversity in the search for new drugs – Spiders, scorpions, horseshoe crabs, sea spiders, centipedes, and millipedes

  2017cites this paper
• Synthetic Approaches to Mono- and Bicyclic Perortho-Esters with a Central 1,2,4-Trioxane Ring as the Privileged Lead Structure in Antimalarial and Antitumor-Active Peroxides and Clarification of the Peroxide Relevance

  2017cites this paper
• Place thérapeutique et biosynthèse de deux immunosuppresseurs d’origine fongique, la ciclosporine A et l’acide mycophénolique

  2017cites this paper
• In Vitro Assessment of Anthelmintic Activities of Rauwolfia vomitoria (Apocynaceae) Stem Bark and Roots against Parasitic Stages of Schistosoma mansoni and Cytotoxic Study

  2017cites this paper
• New Orally Active Artemisinin Dimer Antimalarials

  2017cites this paper
• Synthesis and antimalarial activity of novel bicyclic and tricyclic aza-peroxides

  2016cites this paper
• A simplified and scalable synthesis of artesunate

  2016cites this paper
• Repurposing of antiparasitic drugs: the hydroxy-naphthoquinone buparvaquone inhibits vertical transmission in the pregnant neosporosis mouse model

  2016cites this paper
• Metabolite identification of the antimalarial piperaquine in vivo using liquid chromatography-high-resolution mass spectrometry in combination with multiple data-mining tools in tandem.

  2016cites this paper
• Artesunate inhibits proliferation of naïve CD4+ T cells but enhances function of effector T cells

  2015cites this paper
• Inhibition of Plasmodium berghei Development in Mosquitoes by Effector Proteins Secreted from Asaia sp. Bacteria Using a Novel Native Secretion Signal

  2015cites this paper
• Hit and lead criteria in drug discovery for infectious diseases of the developing world

  2015cites this paper
• Natural Products as Leads in Schistosome Drug Discovery

  2015cites this paper
• Ganoderma lucidum derived ganoderenic acid B reverses ABCB1-mediated multidrug resistance in HepG2/ADM cells.

  2015cites this paper
• Stable Tricyclic Antitubercular Ozonides Derived from Artemisinin.

  2015cites this paper
• Research and perspectives on AP2/ERF transcription factors in medicinal plants

  2015cites this paper
• The Literature of Heterocyclic Chemistry, Part XIII, 2012–2013

  2015cites this paper
• Design of dual action antibiotics as an approach to search for new promising drugs

  2015cites this paper
• Model Studies on Peroxidic Glutathione Transferase (GST) Inhibitors: C5‐Methylated 1,2,4‐Trioxanes with C6‐Acrylate Side Chains

  2015cites this paper
• New Uses for Old Drugs: The Tale of Artemisinin Derivatives in the Elimination of Schistosomiasis Japonica in China

  2014cites this paper
• Artesunate inhibits proliferation of naïve CD4+ T cells but enhances function of effector T cells

  2014cites this paper
• Novel anti-malarial combinations and their toxicity

  2014cites this paper
• Parasite impairment by targeting Plasmodium-infected RBCs using glyceryl-dilaurate nanostructured lipid carriers.

  2014cites this paper
• Aspects of molecular markers in drug resistant malaria

  2014cites this paper
• A review of dihydroartemisinin as another gift from traditional Chinese medicine not only for malaria control but also for schistosomiasis control

  2014cites this paper